Comparison of Outcomes Between Rituximab and Cyclophosphamide for Primary Membranous Nephropathy: A Single Center Experience

被引：0
|
作者：
Hussain, Azm U. [1 ]
Sarween, Nadia [1 ]
机构：
[1] Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2022年 / 33卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
FR-PO654
引用
收藏
页码：502 / 502
页数：1
相关论文
共 50 条
  • [1] Rituximab for the treatment of membranous nephropathy: a single-center experience
    Rigler, Andreja Ales
    Jerman, Alexander
    Orsag, Alesa
    Kojc, Nika
    Kovac, Damjan
    Skoberne, Andrej
    Borstnar, Spela
    Haler, Zeljka Veceric
    Avgustin, Nusa
    Kveder, Radoslav
    Ferluga, Dusan
    Vizjak, Alenka
    Lindic, Jelka
    CLINICAL NEPHROLOGY, 2017, 88 : S27 - S31
  • [2] Comparations of efficacy and safety of rituximab, calcineurin inhibitors and cyclophosphamide in primary membranous nephropathy: a single-center retrospective analysis
    Luying Lu
    Shasha Cai
    Huayan Zhu
    Guangjun Liu
    Yaomin Wang
    Pingping Ren
    Lan Lan
    Xiaoqi Shen
    Liangliang Chen
    Ying Xu
    Jun Cheng
    Xiayu Li
    Jianghua Chen
    Fei Han
    BMC Nephrology, 25 (1)
  • [3] Comparison of Obinutuzumab and Rituximab for Treating Primary Membranous Nephropathy
    Hu, Xiaofan
    Zhang, Muyin
    Xu, Jing
    Gao, Chenni
    Yu, Xialian
    Li, Xiao
    Ren, Hong
    Wang, Weiming
    Xie, Jingyuan
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 19 (12): : 1594 - 1602
  • [4] Single-dose Rituximab Therapy for Refractory Idiopathic Membranous Nephropathy: A Single-center Experience
    Katsuno, Takayuki
    Ozaki, Takenori
    Kim, Hangsoo
    Kato, Noritoshi
    Suzuki, Yasuhiro
    Akiyama, Shinichi
    Ishimoto, Takuji
    Kosugi, Tomoki
    Tsuboi, Naotake
    Ito, Yasuhiko
    Maruyama, Shoichi
    INTERNAL MEDICINE, 2017, 56 (13) : 1679 - 1686
  • [5] Treatment of Membranous Nephropathy in Chinese Patients: Comparison of Rituximab and Intravenous Cyclophosphamide with Steroids
    Hu, Xiaofan
    Ren, Hong
    Xu, Jing
    Gao, Chenni
    Wu, Yifan
    Ouyang, Yan
    Lin, Li
    Li, Xiao
    Liu, Na
    Wang, Weiming
    Xie, Jingyuan
    Chen, Nan
    KIDNEY DISEASES, 2024, 10 (05) : 359 - 368
  • [6] Rituximab bioavailability in primary membranous nephropathy
    Boyer-Suavet, Sonia
    Andreani, Marine
    Cremoni, Marion
    Brglez, Vesna
    Benzaken, Sylvia
    Bernard, Ghislaine
    Nachman, Patrick
    Esnault, Vincent
    Seitz-Polski, Barbara
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 (08) : 1423 - 1425
  • [7] Rituximab Is Preferable to Cyclophosphamide for Treatment of Membranous Nephropathy: CON
    van de Logt, Anne-Els
    Wetzels, Jack F.
    KIDNEY360, 2021, 2 (11): : 1699 - 1701
  • [8] Rituximab Is Preferable to Cyclophosphamide for Treatment of Membranous Nephropathy: COMMENTARY
    Klomjit, Nattawat
    Zand, Ladan
    KIDNEY360, 2021, 2 (11): : 1702 - 1705
  • [9] Rituximab Is Preferable to Cyclophosphamide for Treatment of Membranous Nephropathy: PRO
    Oliva-Damaso, Nestor
    Bomback, Andrew S.
    KIDNEY360, 2021, 2 (11): : 1696 - 1698
  • [10] Low-dose Rituximab therapy in resistant idiopathic membranous nephropathy: single-center experience
    Bagchi, Soumita
    Subbiah, Arun Kumar
    Bhowmik, Dipankar
    Mahajan, Sandeep
    Yadav, Raj Kanwar
    Kalaivani, Mani
    Singh, Geetika
    Dinda, Amit
    Agarwal, Sanjay Kumar
    CLINICAL KIDNEY JOURNAL, 2018, 11 (03) : 337 - 341
12345